More than One-Third of US Adults Say They "Don't Need" Respiratory Virus Vaccines this Fall
Adults saying they don't need immunization this fall have received the vaccines in the past, survey authors report, suggesting a lingering misinformation effect.
RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
Erenumab Induces Remission in Chronic Migraine Medication Overuse Headache
Erenumab 140 mg safely and effectively induced remission in nonopioid MOH within 6 months in individuals for whom other preventive medications had failed.
First Self-Administered Flu Vaccine Approved by US FDA
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
First-Ever CGM Cleared for 365-Day Use
The only CGM system cleared for 1 year of use in type 1 and 2 diabetes is expected to be available in the fourth quarter of this year, the manufacturers said.
ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults
New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.
Tralokinumab for Treatment of AD in Special Populations: Daily Dose
Co-administration of Arexvy and Shingrix Yields Positive Topline Phase 3 Data, GSK Reports
Immune responses for both vaccines were noninferior when given at the same visit compared with separate administration among adults aged 50 years and older.
IPF Update: FIBRONEER-IPF Study of Nerandomilast Meets Primary End Point
The positive pivotal phase 3 trial results showed improved lung function with neradomilast vs placebo and will support BI's US and global NDA submissions.
Long-Term Safety of Roflumilast in Adults with COPD: Daily Dose
Resistant and Refractory Hypertension: A Guideline Topline for Primary Care
Hypertension that is resistant or refractory to treatment increases the risk of comorbidity and cardiovascular risk. Click through this at-a-glance review of key issues.
Novel Oral Antiobesity Drug Shown to Reduce Body Weight by up to 13% in First-In-Human Study
EASD 2024: Amycretin was also found to be safe and well tolerated in adults with obesity and without diabetes.
21 Beliefs about AI in Health Care, from People Like Your Patients
AI is welcomed by US adults for streamlining the administrative complexity of getting medical care but not so much for replacing health care professionals themselves.
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose
FDA Updates Felinzanetant Label Warnings After Report of Severe Liver Injury
FDA heightened label warnings about hepatic injury and increased the required frequency of liver function testing after initiation of fezolinetant.
Good Cardiovascular Health Early on May Offset Genetic Risk of Hypertensive Disorders of Pregnancy
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
A False-Positive Breast Cancer Screening Result Discourages Future Mammography
Those least likely to schedule further screening mammograms had received a false-positive with recommendation for follow-up after only a short interval.
Corticosteroid Phobia among Individuals with Chronic Hand Eczema: Daily Dose
Mental Health Among Adolescents With Obesity: Daily Dose
Lilly Announces FDA Approval of Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis
Among those treated with lebrikizumab, more than one-third saw clear/almost clear skin at week 16; three-quarters of them maintained results at week 52 with monthly dosing.
